Table 1 Patient demographics included in this study
Types of soft tissue sarcomas included in the study | |||
Pathology | Number of cases | Percentage | |
Synovial sarcoma | 10 | 27.77% | |
Rhabomyosacroma RMS | 9 | 24.9% | |
Malignant peripheral nerve sheath tumor MPNT | 2 | 5.55 % | |
Liposarcoma | 4 | 11.1% | |
Leimyosarcoma | 2 | 5.55% | |
Myofibroblastic Sarcoma | 2 | 5.55% | |
Fibrosarcoma | 2 | 5.55% | |
Undifferentiated sarcoma | 3 | 8.3% | |
Round cell tumor | 2 | 5.55 % | |
Post-operative pathology | |||
7 patients | Optimal response | Suboptimal response | No comment on degree of necrosis and tumor viability |
3 | 2 | 2 | |
Site of the primary tumor | |||
Location | Lower extremity | Upper extremity | Trunk |
25/36 | 6/36 | 2/36 | |
Treatment plan | |||
Treatment | Chemotherapy | Concomitant chemo-radiotherapy (CCRTH) | Surgery following chemotherapy |
28/36 (77.7%) | 8/36 (22.2 %) | 7/36 (19.4%) | |
The interval between initial baseline MRI study and the follow-up MRI exams | Ranging from 1 month up to 1-year post-therapy, with an average of about 4.5 months duration of follow up | ||